Terms: = Ovarian cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
183 results:
1. Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated stat3 in ovarian cancer.
Martincuks A; Zhang C; Austria T; Li YJ; Huang R; Lugo Santiago N; Kohut A; Zhao Q; Borrero RM; Shen B; Cristea M; Wang EW; Song M; Rodriguez-Rodriguez L; Yu H
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580335
[TBL] [Abstract] [Full Text] [Related]
2. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in ovarian cancer SKOV3-TR Cells.
Lim YJ; Kim HS; Bae S; So KA; Kim TJ; Lee JH
Molecules; 2024 Jan; 29(1):. PubMed ID: 38202856
[TBL] [Abstract] [Full Text] [Related]
3. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
4. Mechanisms of carboplatin- and paclitaxel-dependent induction of premature senescence and pro-cancerogenic conversion of normal peritoneal mesothelium and fibroblasts.
Rutecki S; Pakuła-Iwańska M; Leśniewska-Bocianowska A; Matuszewska J; Rychlewski D; Uruski P; Stryczyński Ł; Naumowicz E; Szubert S; Tykarski A; Mikuła-Pietrasik J; Książek K
J Pathol; 2024 Feb; 262(2):198-211. PubMed ID: 37941520
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
6. 3'-Hydroxypterostilbene Potently Suppresses Tumor Growth via Inhibiting the Activation of the JAK2/stat3 Pathway in ovarian Clear Cell Carcinoma.
Koh YC; Huang WZ; Nagabhushanam K; Ho CT; Pan MH
Mol Nutr Food Res; 2024 Jan; 68(1):e2300108. PubMed ID: 37876143
[TBL] [Abstract] [Full Text] [Related]
7. Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/stat3/GANAB axis.
Wang X; Chen Q; Bing Z; Zhou S; Xu Z; Hou Y; Zhao Y; Zhao S; Wang T
Int J Biol Sci; 2023; 19(14):4672-4688. PubMed ID: 37781028
[No Abstract] [Full Text] [Related]
8. Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary.
Mori H; Nishida H; Kusaba T; Kawamura K; Oyama Y; Daa T
Medicine (Baltimore); 2023 Sep; 102(37):e35301. PubMed ID: 37713813
[TBL] [Abstract] [Full Text] [Related]
9. PIK3R6 Promotes Angiogenesis in Hepatocellular carcinoma by Activating stat3 Signaling Pathway.
Du Y; Zhao W; Han H; Ren L; Ding M; Wang Y
Altern Ther Health Med; 2023 Nov; 29(8):704-709. PubMed ID: 37708538
[TBL] [Abstract] [Full Text] [Related]
10. Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
Zhang X; Guo H; Chen J; Xu C; Wang L; Ke Y; Gao Y; Zhang B; Zhu J
Cancer Lett; 2023 Sep; 572():216355. PubMed ID: 37597651
[TBL] [Abstract] [Full Text] [Related]
11. AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/stat3 axis.
Wu Y; Xu M; Feng Z; Wu H; Wu J; Ha X; Wu Y; Chen S; Xu F; Wen H; Li S; Wu X
Cell Mol Life Sci; 2023 Aug; 80(9):256. PubMed ID: 37589744
[TBL] [Abstract] [Full Text] [Related]
12. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/stat3 signaling.
Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
[TBL] [Abstract] [Full Text] [Related]
13. Curcumin potentiates the anti-inflammatory effects of Tehranolide by modulating the stat3/NF-κB signaling pathway in breast and ovarian cancer cell lines.
Afshari H; Noori S; Zarghi A
Inflammopharmacology; 2023 Oct; 31(5):2541-2555. PubMed ID: 37452228
[TBL] [Abstract] [Full Text] [Related]
14. Potentiation of Cisplatin Cytotoxicity in Resistant ovarian cancer SKOV3/Cisplatin Cells by Quercetin Pre-treatment.
Hasan AA; Kalinina E; Nuzhina J; Volodina Y; Shtil A; Tatarskiy V
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446140
[TBL] [Abstract] [Full Text] [Related]
15. CD109 Promotes Drug Resistance in A2780 ovarian cancer Cells by Regulating the stat3-NOTCH1 Signaling Axis.
Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
[TBL] [Abstract] [Full Text] [Related]
16. Adenosine receptor A2b confers ovarian cancer survival and PARP inhibitor resistance through IL-6-stat3 signalling.
Chi L; Huan L; Zhang C; Wang H; Lu J
J Cell Mol Med; 2023 Aug; 27(15):2150-2164. PubMed ID: 37278400
[TBL] [Abstract] [Full Text] [Related]
17. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
18. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/stat3 and MAPKs signaling pathways.
Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F
Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479
[TBL] [Abstract] [Full Text] [Related]
19. Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human ovarian cancer and by Regulation of the IL-6/stat3/FoxO3a Pathway.
Park SA; Seo YJ; Kim LK; Kim HJ; Yoon KD; Heo TH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047012
[No Abstract] [Full Text] [Related]
20. Indoxyl Sulfate Promotes Metastatic Characteristics of ovarian cancer Cells via Aryl Hydrocarbon Receptor-Mediated Downregulation of the Mas Receptor.
Saito S; Koya Y; Kajiyama H; Yamashita M; Nawa A
Lab Invest; 2023 Mar; 103(3):100025. PubMed ID: 36925201
[TBL] [Abstract] [Full Text] [Related]
[Next]